Product Program year 2020 Source: CMS Open Payments

Guardian Sensor 3

Device Continuous Glucose Monitoring

Open in the dashboard

General payments

$2,176

77 payments

Research payments

$5,746,340

266 payments

Through program year 2020, $2,176 in general payments and $5,746,340 in research payments were reported against Guardian Sensor 3 (Continuous Glucose Monitoring).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $1,167 25
2020 Research $3,081,513 200
2019 General $1,009 52
2019 Research $2,664,827 66

Breakdown

Who paid General payments · program years 2019–2020
  1. Medtronic MiniMed, Inc. $2,087 72 payments
  2. Medtronic, Inc. $89 5 payments
Top recipients General payments · program year 2020
  1. Scott Lee Endocrinology, Diabetes & Metabolism · Loma Linda, CA $682 58% · 2 payments
  2. Samer Nakhle Endocrinology, Diabetes & Metabolism · Las Vegas, NV $111 9% · 2 payments
  3. Nicholas Vernetti Endocrinology, Diabetes & Metabolism · Las Vegas, NV $111 9% · 2 payments
  4. Robert Kimmel Endocrinology, Diabetes & Metabolism · Puyallup, WA $81 7% · 5 payments
  5. Mohammed Nizam Endocrinology, Diabetes & Metabolism · Provo, UT $27 2% · 2 payments

The top 5 of 16 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $1,076 92% · 9 practitioners
  2. Internal Medicine $50 4% · 4 practitioners
  3. Family Medicine $26 2% · 2 practitioners
  4. Podiatrist $15 1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. California $682 58% · 1 recipient
  2. Nevada $245 21% · 4 recipients
  3. Washington $106 9% · 3 recipients
  4. Utah $41 4% · 2 recipients
  5. Texas $39 3% · 2 recipients

The top 5 of 8 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

77 general · 266 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record